"For now, the appropriate way to act on this work is to ensure that people with colon cancer who also have obesity or diabetes are offered guideline-supported metabolic therapies, including GLP-1 agents when clinically indicated, as part of comprehensive care." The researcher emphasized that this is a "hopeful signal rather than a final answer." "It suggests that we may be able to improve cancer outcomes by treating the whole person and not just the tumor, and that modern metabolic therapies could have unanticipated benefits for patients with malignancy," he said
It also helps regulate homocysteine levels, promoting cardiovascular health
PMID: 12835106 Coppola L, Grassia A, Giunta R, Verrazzo G, Cava B, Tirelli A, DOnofrio F
New Clinical Practice Guidelines for OSA Treatment Options The AASM is aware that $327,000 grant will support awareness efforts aimed atpreventing unnecessary deaths, improving sleep quality, and minimizing co-morbidities (1)